# Vor Biopharma Inc.: Form SCHEDULE 13D/A, filed Apr 1, 2026

- Company: [Vor Biopharma Inc.](/companies/vor.md) (CIK 1817229)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-01
- Accepted by EDGAR: Apr 1, 2026, 17:09 ET
- Period: not reported
- Accession: 0001346824-26-000090
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817229/000134682426000090/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817229/000134682426000090/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817229/000134682426000090/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001346824-26-000090. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.